480
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients

, , , , , , , , & show all
Pages 473-480 | Received 16 Jun 2011, Accepted 08 Nov 2011, Published online: 11 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. Baumgart, K. Nilsson, A. Stavreus Evers, T. Kunovac Kallak, M. M. Kushnir, J. Bergquist & I. Sundström Poromaa. (2014) Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients. Climacteric 17:1, pages 48-54.
Read now

Articles from other publishers (13)

Ruth Andrew & Natalie Z.M. Homer. (2020) Mass spectrometry: Future opportunities for profiling and imaging steroids and steroid metabolites. Current Opinion in Endocrine and Metabolic Research 15, pages 71-78.
Crossref
Kentaro Hayashi, Tina K. Gonzales, Amita Kapoor, Toni E. Ziegler, Sivan Vadakkadath Meethal & Craig S. Atwood. (2020) Development of Classification Models for the Prediction of Alzheimer’s Disease Utilizing Circulating Sex Hormone Ratios. Journal of Alzheimer's Disease 76:3, pages 1029-1046.
Crossref
R.T. Pavlović, S.M. Janković, J.R. Milovanović, S.M. Stefanović, M.M. Folić, O.Z. Milovanović, C. Mamillapalli & M.N. Milosavljević. (2019) The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis. Clinical Breast Cancer 19:6, pages e731-e740.
Crossref
Laura Smy & Joely A. Straseski. (2018) Measuring estrogens in women, men, and children: Recent advances 2012–2017. Clinical Biochemistry 62, pages 11-23.
Crossref
Joseph H. Huntley, Lee A. Richter, Amanda L. Blackford, Oluseyi Aliu & Craig E. Pollack. (2018) Topical Estrogen Prescription Fill Rates for Women With a History of Breast Cancer Who Are Taking Hormone Therapy. Obstetrics & Gynecology 132:5, pages 1137-1142.
Crossref
Carolyn J. Crandall, Kathleen M. Hovey, Christopher A. Andrews, Rowan T. Chlebowski, Marcia L. Stefanick, Dorothy S. Lane, Jan Shifren, Chu ChenAndrew M. Kaunitz, Jane A. Cauley & JoAnn E. Manson. (2018) Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause 25:1, pages 11-20.
Crossref
Michelle E. Melisko, Mindy E. Goldman, Jimmy Hwang, Amy De Luca, Sally Fang, Laura J. Esserman, Amy J. Chien, John W. Park & Hope S. Rugo. (2017) Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer. JAMA Oncology 3:3, pages 313.
Crossref
Xin Yi, Edward Ki Yun Leung, Rachael Bridgman, Selene Koo & Kiang-Teck J Yeo. (2016) High-Sensitivity Micro LC-MS/MS Assay for Serum Estradiol without Derivatization. The Journal of Applied Laboratory Medicine 1:1, pages 14-24.
Crossref
Masami Morimoto, Masako Takahashi, Junko Honda, Takahiro Yoshida, Mitsuteru Yoshida, Hiroaki Toba, Issei Imoto, Akira Tangoku & Mitsunori Sasa. (2016) Assay of serum E2 concentration in postmenopausal breast cancer patients using a high-sensitivity RIA method is generally useful. The Journal of Medical Investigation 63:3.4, pages 236-240.
Crossref
Theodora Kunovac Kallak, Juliane Baumgart, Kerstin Nilsson, Helena Åkerud, Inger Sundström Poromaa & Anneli Stavreus-Evers. (2015) Vaginal Gene Expression During Treatment With Aromatase Inhibitors. Clinical Breast Cancer 15:6, pages 527-535.e2.
Crossref
Caroline Antoine, Lieveke Ameye, Marianne Paesmans & Serge Rozenberg. (2014) Treatment of climacteric symptoms in breast cancer patients: A retrospective study from a medication databank. Maturitas 78:3, pages 228-232.
Crossref
Theodora Kunovac Kallak, Juliane Baumgart, Emma Göransson, Kerstin Nilsson, Inger Sundström Poromaa & Anneli Stavreus-Evers. (2014) Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors. Menopause 21:4, pages 383-390.
Crossref
Deanna M. Janzen, Daniel Y. Paik, Miguel A. Rosales, Brian Yep, Donghui Cheng, Owen N. Witte, Huseyin Kayadibi, Christopher M. Ryan, Michael E. Jung, Kym Faull & Sanaz Memarzadeh. (2013) Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo . Molecular Cancer Therapeutics 12:12, pages 2917-2928.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.